




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
ZhejiangU-REALMedicalTechnologyCo.,Ltd.VacuCyte
VacuumBloodCollectionTubes?CONTENTS1、OurCompany2、OurMission3、OurProducts4、AboutBloodCollection1、OURCOMPANYName:ZhejiangU-REALMedicalTechnologyCo.,Ltd.Founded:July4th,2006President:Mr.HuibinShiNatureofBusiness:Manufacturinganddevelopingmedicaldevicesandprovidingservicesforthoseproducts.NumberofEmployees:82Production:22Salespeople:28R&D:6NEWFACTORYAddress:JiangkouZhongxiaoPark,HuangyanEconomicDevelopmentZone,Taizhou,Zhejiang,People’sRepublicofChinaYearOn-line:2010Size:6,630m2Numberofproductionlines:4Annualcapacity:>350millionOURCERTIFICATIONSISO9001:2000ISO13485CEMarkCOMPANYSTRUCTUREU-REALcomprisesof:AvibrantScientificResearch&Developmentlaboratory,Productionfacilitieswhichemploysomeofthemostadvancedmanufacturingtechnology,ofourdiligentandefficientMarketingandSalesteams,andourfriendlyandhelpfulCustomerService.2、OURMISSIONOurmissionistotakealeadingroleintheenhancementofhealthcareservicesbothinChinaandabroadthroughthedevelopment,manufacture,andsupplyofsuperiorqualityproductstohealthcareprofessionals.3、OURPRODUCTSOURPRODUCTSExtrasPETvs.GlassTheVacuumSeal
TheSafetyCapOurAdditivesVacuCyteLineU-MBCT??PETvs.GlassOurPETtubesaremadeofhighqualityresinusingprecisemoulds.Thetubes’interiorsurfaceisfinelyandevenlycoatedwithsiliconoil,ensuringtransparency,smoothness,andchemicalstability.PETtubesaresuperiortoglasstubesfortheir
Durability,Safety,andStability.SafetyDuringbloodcollectionandtesting,medicalprofessionalsmayaccidentallybeexposedtobloodandriskinfectionstodiseasessuchasAIDSorhepatitis.Ourimpact-resistantPETtubesandoursafetycaps’rubberstoppersgreatlylimitthatrisk,helpingmakethehospitalasaferworkingenvironment.StabilityBecauseouradvancedseparatinggelbindsstronglytotheinnerwallsofourPETtubes,theycanbeheldincoldstorageforupto10dayswithoutanyspecimendeterioration,whichwouldbenearlyimpossiblewithaglasstube.Neithervibrationsnorimpactswillgenerateleakagesthatcompromisethespecimens’separation.MorePETTubeAttributesPETtubesarelighterthanglasstubes.OurPETtubes’transparencymatchethatofglass,allowingtheusertoquicklyandaccuratelyrecognizeseparation,coagulation,hemolytic,andotherconditions.Biochemistryandimmunitytestresultsshowvirtuallynodifferencecomparedtoglasstubes.THESAFETYCAPVacuCytesafetycapsareergonomicallydesignedforeffectivegripandremoval.Withtheuser’ssafetyinmind,therubbersealfunctionsasashield,preventingbackflowandeliminatingexposuretothebloodspecimen.OurcapsarecolorcodedaccordingtoInternationalstandards.?OURADDITIVESU-REALisproudofthewayitsourcesitscomponents,alwaysstrivingtofindthebestadditivesfromthemostreliablepartners.Weemploythelatesttechnologyinapplyingreagentstothetubes,maximizingtheireffectbyensuringthatanaccuratequantityfinelyandevenlycoatstheinteriorwall.OURVACUCYTE
LINEVacuCytetubescanbedividedintwogroupsbasedonthepurposeoftheiradditives:1、Pro-coagulants2、Anti-coagulants??BloodSerumAftercollectingblood,gentlyturningthetube6-8times,andwaiting15-30minutes,thetubeshouldbeplacedinacentrifuge.Thiswillcompletetheseparationofclear,yellowserumfromred,clottedblood.Bloodserumiswhatisleftofbloodafteryouremovethecellsandthecoagulationfactors.Itretainsotherproteins,antigens,antibodies,electrolytes,andexogenoussubstanceslikedrugsandmedicine.BloodSerumvs.BloodPlasmaSerumdiffersfromPlasma,whichstillcontainsthecoagulationfactors.Water,electrolytes,non-coagulatingproteins;nocellularcomponentsFibrinogensandotherclottingfactorsBloodcellsandothercellularcomponentsBloodSerumBloodplasmaSerumTubeClotActivatorAttributesTheClotActivatoronthetube’sinnerwallwillautomaticallygenerateamembranewhenitcomesintocontactwithblood,clottingcompletelyinashorttime.WithouttheClotActivator,coagulationwillnormallyrequire5-6hours,asopposedto30minuteswithit.Ifthetubeisproperlyturnedafterbloodcollection,coagulationcanoccurinaslittleas10minutes.ClotActivatorAttributes(cont.)Ouradvancedformularesultsinmoderatecoagulationinarelativelyshorttime,voidingpossiblehemolyticproblemswhichcanarisefromtoorapidclotting.Ifthetubeisproperlyturnedand15-30minutesaregivenforcoagulationtooccurbeforecentrifugation,nofibrinwillremaininthesampleavoidinginadequateresultsandpotentialcloggingdamagetolabequipment.SeparatingGelAttributesOuradvancedSeparatingGelformulacompletelyseparatesserumfromclottedblood,formingaprominent,impermeablebarrierbetweenthespecimens.Aftercentrifugation,thegelwillbefirmlyattachedtothetube’sinnerwall,sothatneithervibrationsnorimpactswillgenerateleakagesthatcompromisethespecimens’separation.PrecautionswithSeparatingGelStorage:4-25°CTurning:aftercollection,gentlyturnthetube6-8times.Recommendedcoagulationtime:setthetubeuprightfor15-30minutesbeforecentrifugation.IdealCentrifugeSpeed:3500rpmIdealCentrifugeTemperature:25°CAnti-CoagulantTubesThereareseveralkindsoftubescontainingdifferentanti-coagulantsfordifferentpurposes:1)EDTATube2)PlasmaTube3)CoagulationTube4)ESRTube5)FluorideandOxalateTubeEDTATubeEDTATubesEDTA,whichchaletscalciumionsinordertoinhibitthecoagulationcascade,hasusesinhematologytesting.In
routinebloodexaminationsitcanrevealredandwhitebloodcellandplateletcountsandindices,hematocritorpackedcellvolume,andhemoglobinconcentration.EDTATubesTheoptimalEDTAconcentrationis1.8mg/mlblood.Weapplythequantitativeultra-fineatomizedsprayingandinstantdryingtechnology,inorderforapreciseamountofadditivetofinelyandaccuratelycoattheinteriorwall.Thisensuresquickmixingwiththeblood,thusenhancingtheanticoagulationeffects.U-REALoffersbothEDTAK2andK3.PrecautionswithEDTADependingonthespecimens,itmaycauseaconditionofplateletaggregation.BecauseEDTAallowsCalcium,Magnesium,Iron,andZinctobedetectedbychelatingthem,andtheseelementsarenecessaryforthestabilityandexpressionofenzymes,thesetubescannotbeusedforemergencytesting.PlasmaTubesPlasmaTubesThePlasmaTubescontainHeparinLithiumorHeparinSodiumasanti-coagulants,which,byactivatinganti-thrombins,inhibitthecoagulationcascade.Thesetubesareusefulforbiochemicaltestingandespeciallyinemergencysituations,wherehemorheologytestingisvitalfordeterminingappropriatetreatmentprocedures.PlasmaTubes16IUheparincananti-coagulate1mlofblood.Ourtechnologyensuresanevenandsufficientamountofadditiveispresentineachtube,resultinginidealsamplesforthelab.Plasmatubesarealsoavailablewithseparatinggel.HeparinandGeltubeshavelightgreencaps.PrecautionswithPlasmaTubesHeparinLithiumandHeparinSodiumbothstronglyaffectbloodcellshapeandarethusnotsuitableforhematologytests.ThereisvirtuallynodifferencebetweenresultsusingHeparinSodiumorLithium,butwhenusingHeparinSodium,bloodplasmasodiumlevelsmaybeslightlyhigher.ThesameistrueoflithiumlevelswhenusingHeparinLithium.CoagulationTubesCoagulationTubesThesetubescontainabufferedSodiumCitratesolutionwithaconcentrationof3.2%.SodiumCitratedisruptsthebloodclottingmechanismbychelatingcalciumions.Inourformula,onepartSodiumCitratecananti-coagulate9partsblood.Coagulationtestsprovideinformationaboutplateletcountandfunctions,andactivationtimesforseveralfactorsinthecoagulationcascade’spathways.ESRTubesESRTubescontaina3.8%SodiumCitratesolution,whereonepartanti-coagulatesfourpartsblood.ESRstandsforerythrocytesedimentationratetests.Inthesetests,anti-coagulatedbloodisplacedinatube,andthequantityofredbloodcellsprecipitatingInonehourismeasuredinmm.ESRTubesESRTubesThesenon-specifictests,whoseresultsindicatethepresenceofinflammations,areusedalongwithotherteststodetectandmonitorinfections,cancers,andanumberofotherconditions,aswellastreatmentprogress.PrecautionswithSodiumCitrateTheratioofSodiumCitratetobloodisextremelyimportantforadequatetestresults.Thetubes’labelscontainamarkerfortherequiredamountofbloodtobecollected,buteveryyeartherequiredamountofbloodwilldropbymoreorless10%asthetubelosesitsvacuumpressure.Therefore,thesetubesonlyhavea1yearshelflife.FluorideandOxalateTubesFluorideandOxalateTubesGraycaptubesareutilizedfortestingbloodglucoseandlactate.SodiumFluoridecombineswithCalciumionstoformCAF2andpreventsthedecompositionofglucosebyblockingtheenolaseenzyme.
InadditiontoSodiumFluoride,thesetubescontainananticoagulantsuchasPotassiumOxalateorEDTA.U-MBCT?U-MBCTU-MBCT
tubesaremainlyusedforperipheralbloodcollection.Theyareespeciallysuitableforsmallchildrenandgeriatricpatients.U-MBCTproductsfeatureaspeciallydesignedcapforsealingthecontainer.Theinnersurfacehasanexcellenthemrepellency,necessaryforthepreparationofahighqualitybloodsample.Thebar-codedlabelsenableprocessinginautomatedlaboratories.???EXTRASU-REALcanalsoofferavarietyofneedlesandneedleholders.4、ABOUTBLOODCOLLECTIONTheBloodCollectionProcessThingstoAvoidUnwantedResultsPrecautionsTHEBLOODCOLLECTIONPROCESS1.Extractblood2.Turnthetube3.StoreuprightatroomtemperatureBloodCollectionPositionForadults,theveinontheinsideoftheelbowispreferred.Ifthepatientisreceivingintravenousfluids,bloodshouldbecollectedfromtheotherarm.Whencollectingbloodformultipletubeswithabutterflyneedle,discardthefirstblood.UsingaButterflyNeedleButterflyneedlescanbeusedtocollectbloodformultipletubes.Whenusingabutterflyneedle,thefirsttubeusedshouldbeayelloworredcaptube.Becausetheairinitiallyinthebutterflyneedlereducesthevacuumofthetube,thevolumecollectedwillbelessthanrequired,andonlythesetubescanprovideadequateresultswithlowerquantitiesofblood.UsingaButterflyNeedleFurther,whentheneedlefirstpuncturestheskin,someofthebody’snaturalclotactivatingmechanismsmayenterthetubeandbegincoagulationactivity.Thisisnotdesirablewithanti-coagulanttubes.BecausecollectedvolumeisessentialtoappropriateresultswithSodiumcitratetubes,werecommendthatthebluecaptubesarethesecondtubeusedwhenusingabutterflyneedle.RecommendedCollectionOrderYellowBlueGreenGrayPurpleRedBlack123456orTHINGS
TOAVOIDImproperCollectionHemolyticFibrinPrecipitationBloodCellsRemainingintheSerumImproperPost-collectionProceduresTheAnglingoftheNeedleintotheNeedleHolderThetubemustbeinsertedparalleltotheneedleholder.Otherwise,theneedlemightnotproperlypenetratethecap’srubberstopper.Iftheangleisskewed,youmaymeetsomeresistancefromtheneedletopuncturetherubber.Ifso,itisbesttowithdrawthetubeandreinsertattheproperparallelangle.Incorrectinsertion
ProperparallelinsertionNeedleIssuesLeadingtoInadequateCollectionWhenusingyourthumbtopressthetubeontotheneedleintheholder,makesurethatthetubedoesnotcomeofftheneedlewhenyouremoveyourthumb’spressure.Ifthishappens,useyourthumbtopushthetubebackontotheneedle.NeedlenotfullyintubeUsingAppropriateTubesfortheDesiredDrawVolumeIfinsufficientbloodiscollected,residualvacuuminthetubesaftercollectionmayleadtohemolytic,andparticlesreleasedbytheburstcellsmayaffecttestresults.Tubeswithinappropriatelevelsofadditivesshouldnotbeused.TheratioofsodiumcitratetobloodisessentialforcoagulationandESRtests;excessEDTAwillincreaseosmoticpressureandaffecthematologytestresults.HemolyticRedbloodcellsmayburstforanumberofdifferentreasons.Thisiscalledhemolytic.Ifthisoccurs,hemoglobinandothercomponentsoftheredbloodcellwillbereleasedintothebloodplasma,whichcanaffecttestresults.FactorsLeadingtoHemolyticContactwithwater:Waterhasalowerosmoticpressurethanblood,andthisdifferencecancausethecellstorupture.Foaming:Intensemotioncancausebloodtofoam.Iftheredbloodcellscomeintocontactwithair,theirmembranesmaydryout,theywilllosesurfacetension,andhemolyticwilloccur.Decompression:Lowerpressurewillalsocausethecelltodenatureandburst.Physicaldamagetocells:Strongimpacts,heavyshaking,orotherintensemotionsmaycausecellstorupture.FibrinPrecipitationCoagulationnormallyoccurswhenfibrininteractswithotherfactorsinthebloodtoformaclot.Bloodclotsaredenserthangel,sotheycanbeseparatedfromserum.However,fibrinandbloodcellsrepeleachotherandifsomebloodclotscan’tformcompletely,fibrinwillprecipitate.Becauseitislessdensethangelandattachedtotheclots,itmaythencreateagapinthegel,contaminatingtheserumspecimen,andaffectingthetestresults.FibrinPrecipitationFactorsLeadingtoFibrinPrecipitationInadequateturning:Thetube’sinnerwalliscoatedwithcoagulant,andifthetubeisn’tproperlyturned,theadditivewillnotsufficientlymixwiththeblood.Ifbecauseenoughtimeisn’tgivenorenoughadditiveisn’tused,insufficientcoagulationbeforecentrifugationwillcauseincompletelyformedclotsandfibrinprecipitation.AvoidingFibrinPrecipitationAfterbloodcollection,makesuretoturnthetube8-10timesslowly,sothattheadditivemixeswellandtopreventanyleaksatthestopper.Afterturning,waitfor15to20minutesbeforeplacingthetubeinthecentrifuge.Thiswaythereisenoughtimeforthebloodtocompletelycoagulate.ImproperPost-collectionProcedureCoagulationconditions:Turnthetubewell,setitupright,andwaitlongenoughforclottingtooccur.Centrifugationconditions:Setappropriatecentrifugation
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 蘇科版九年級數(shù)學(xué)上冊《6.5相似三角形的性質(zhì)》同步測試題及答案
- 生物化實(shí)驗(yàn)考試試題及答案
- 化學(xué)實(shí)踐學(xué)習(xí)(下學(xué)期)成果評估試題
- 固安教師考試題目及答案
- 拱型路面考試題目及答案
- 公司財(cái)務(wù)考試題及答案
- 德州數(shù)學(xué)新課標(biāo)考試題及答案
- 高職語文新編考試題及答案
- 高空車作業(yè)考試題及答案
- 童話故事中的友誼話題(8篇)
- 2025年中國郵政集團(tuán)工作人員招聘考試筆試試題(含答案)
- 常見“肩痛”診斷、鑒別診斷與治療
- 冷水灘事業(yè)編招聘2022年考試《公共基礎(chǔ)知識》真題及答案解析【完整word版】
- GB/T 4892-2008硬質(zhì)直方體運(yùn)輸包裝尺寸系列
- 插件基礎(chǔ)知識培訓(xùn)(電子)課件
- 2016 年全國中學(xué)生天文奧林匹克競賽預(yù)賽試卷
- 2022加油站安全生產(chǎn)責(zé)任制考核臺(tái)帳
- 機(jī)器視覺技術(shù)及應(yīng)用全套課件完整版電子教案最新板
- 中醫(yī)科質(zhì)量與安全管理小組活動(dòng)記錄
- DB32∕T 1365-2009 斜拉橋拉索減振設(shè)計(jì)指南
- 松巖冶金材料(全南)有限公司全南生產(chǎn)基地氟鹽項(xiàng)目21
評論
0/150
提交評論